134 related articles for article (PubMed ID: 8090451)
1. Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors.
Glacet-Bernard A; Chabanel A; Lelong F; Samama MM; Coscas G
Ophthalmology; 1994 Sep; 101(9):1483-7. PubMed ID: 8090451
[TBL] [Abstract][Full Text] [Related]
2. Role of rheologic factors in patients with acute central retinal vein occlusion.
Arend O; Remky A; Jung F; Kiesewetter H; Reim M; Wolf S
Ophthalmology; 1996 Jan; 103(1):80-6. PubMed ID: 8628564
[TBL] [Abstract][Full Text] [Related]
3. [Increase of erythrocyte aggregation in retinal vein occlusion].
Glacet-Bernard A; Chabanel A; Coscas G; Lelong F; Samama M
J Fr Ophtalmol; 1990; 13(10):500-5. PubMed ID: 2081840
[TBL] [Abstract][Full Text] [Related]
4. [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion].
Glacet-Bernard A; Coscas G; Lelong F; Chabanel A; Samama M; Taccoen A
Bull Soc Ophtalmol Fr; 1989 Dec; 89(12):1393-6. PubMed ID: 2632113
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for retinal vein occlusion: prospective study of 175 cases.
Glacet-Bernard A; Coscas G; Chabanel A; Zourdani A; Lelong F; Samama MM
Ophthalmology; 1996 Apr; 103(4):551-60. PubMed ID: 8618752
[TBL] [Abstract][Full Text] [Related]
6. Increased red blood cell aggregation in retinal vein occlusion.
Chabanel A; Glacet-Bernard A; Lelong F; Taccoen A; Coscas G; Samama MM
Br J Haematol; 1990 May; 75(1):127-31. PubMed ID: 2375911
[TBL] [Abstract][Full Text] [Related]
7. [The effect of plasmapheresis on the rheological properties of the blood in patients with thrombosis of the central retinal vein].
Komashchuk AS; Zhaboedov GD; Karpovich LG
Lik Sprava; 1999 Mar; (2):45-7. PubMed ID: 10424039
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion.
Wautier MP; Héron E; Picot J; Colin Y; Hermine O; Wautier JL
J Thromb Haemost; 2011 May; 9(5):1049-55. PubMed ID: 21362128
[TBL] [Abstract][Full Text] [Related]
9. Branch retinal vein occlusion: the pathogenetic role of blood viscosity.
Piermarocchi S; Segato T; Bertoja H; Midena E; Zucchetto M; Girolami A; Procidano M; Mares M
Ann Ophthalmol; 1990 Aug; 22(8):303-11. PubMed ID: 2221710
[TBL] [Abstract][Full Text] [Related]
10. Rheologic findings in patients with acute central retinal artery occlusion.
Kieswetter H; Körber N; Jung F; Reim M
Graefes Arch Clin Exp Ophthalmol; 1983; 220(2):92-5. PubMed ID: 6862190
[TBL] [Abstract][Full Text] [Related]
11. Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution.
Wiek J; Schade M; Wiederholt M; Arntz HR; Hansen LL
Br J Ophthalmol; 1990 Nov; 74(11):665-9. PubMed ID: 2223704
[TBL] [Abstract][Full Text] [Related]
12. Effect of isovolemic hemodilution in central retinal vein occlusion.
Glacet-Bernard A; Zourdani A; Milhoub M; Maraqua N; Coscas G; Soubrane G
Graefes Arch Clin Exp Ophthalmol; 2001 Dec; 239(12):909-14. PubMed ID: 11820695
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group.
Arch Ophthalmol; 1996 May; 114(5):545-54. PubMed ID: 8619763
[TBL] [Abstract][Full Text] [Related]
14. Haemorheology in patients with branch retinal vein occlusion with and without risk factors.
Remky A; Arend O; Jung F; Kiesewetter H; Reim M; Wolf S
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S8-12. PubMed ID: 8871143
[TBL] [Abstract][Full Text] [Related]
15. Hemorheologic variables in critical limb ischemia before and after infrainguinal reconstruction.
Holmberg A; Sandhagen B; Bergqvist D
J Vasc Surg; 2000 Apr; 31(4):691-5. PubMed ID: 10753276
[TBL] [Abstract][Full Text] [Related]
16. [Factor VIII/Ag (von Willebrand) and protein C. Erythrocyte deformability and aggregability. The risk parameters of retinal vein occlusion].
Cortinovis A; Crippa A; Crippa M
Minerva Med; 1994 May; 85(5):211-9. PubMed ID: 8028749
[TBL] [Abstract][Full Text] [Related]
17. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.
Williamson TH; Rumley A; Lowe GD
Br J Ophthalmol; 1996 Mar; 80(3):203-8. PubMed ID: 8703856
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia, a biochemical tool for differentiating ischemic and nonischemic central retinal vein occlusion during the early acute phase.
Lahiri KD; Mukherjee S; Ghosh S; Mukherjee S; Dutta J; Datta H; Das HN
Korean J Ophthalmol; 2015 Apr; 29(2):86-91. PubMed ID: 25829824
[TBL] [Abstract][Full Text] [Related]
19. Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population.
Dong N; Xu B; Tang X
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4057-62. PubMed ID: 24906854
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
Lip PL; Blann AD; Jones AF; Lip GY
Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
